Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Pharm Res. 2012 Jun;29(6):1544–1561. doi: 10.1007/s11095-012-0666-z

Figure 3. A wide diversity in both chemical structure (A) and activity (B) for UGT1A9 substrates in this work.

Figure 3

Panel A: Overview of all aligned structures in training set and test set (n=166).Panel B: UGT1A9 activity distribution (expressed as log(CLint)) of the training and test set.